THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINES (CAM) AMONG PATIENTS WITH CANCER- A DESCRIPTIVE STUDY

Author(s)

Farooqui M*1;Hassali AA2;Shattar AK3;Shafie AA3;Farooqui MA4;Saleem F3, Ul Haq N5 1Universiti Teknologi MARA, Penang, Malaysia, 2Discipline of Social & Administrative Pharmacy, Universiti Sains Malaysia, Pinang, Palau Pinang, Malaysia, 3Universiti Sains Malaysia, Penang, Malaysia, 4Allianze University College Of Medical Sciences, Penang, Malaysia, 5Universiti Sains Malaysia, Penang, P. Penang, Malaysia

OBJECTIVES: To evaluate the prevalence and patterns of CAM use among cancer patients in Malaysia. In addition, the study focuses on the perceived effectiveness of CAM over conventional therapies, information seeking behaviour and CAM disclosure to health care providers. METHODS: The study was designed as a questionnaire based, cross sectional analysis. A prevalence based sample of 393 cancer patients attending the oncology clinics at Penang General Hospital was hereby selected for the study. Adult patients (18 years old), having diagnosed with cancer (any type), able to read or understand Malay (national language of Malaysia) or English language were recruited between August to November 2011. RESULTS: Overall, 393 questionnaires were completed and included in the analysis, showing that 46.1% of cancer patients had used CAM, with most (57.6%) believing that CAM therapies assisted the body’s natural forces to heal. CAM usage was significantly associated with gender (P=0.021), level of education (P=0.001), employment status (P=0.02) and monthly income (P<0.001). Among the frequently used CAM were biologically-based therapies including nutritional supplements (used by 75.5% of the participants). Friends and family members were the most common source of CAM information (for 75.5% of the participants). Only 13% reported side effects from using CAM. CAM use disclosure to the doctors was 43%; however, doctors had specifically asked about CAM use in 33.4% of the cases. The most common reason given for non-disclosure was ‘it is not important for the doctors to know about CAM use (34.2 %). CONCLUSIONS: Cancer management and treatment requires compliance to effective therapies at early stages. Health care providers should engage cancer patients in an open non-judgmental dialogue to ascertain better understanding of cancer and its treatment options.

Conference/Value in Health Info

2013-05, ISPOR 2013, New Orleans, LA, USA

Value in Health, Vol. 16, No. 3 (May 2013)

Code

PCN123

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Treatment Patterns and Guidelines

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×